Literature DB >> 7238474

Comparison and possible homology of isozymes of adenosine deaminase in Aves and humans.

H Ratech, G J Thorbecke, G Meredith, R Hirschhorn.   

Abstract

Two kinetically distinct adenosine deaminase (ADA) isozymes with different molecular weights (35,000 and 100,000 daltons) are found in chicken liver in approximately equal amounts. The 100,000-dalton ADA has a markedly higher Km for adenosine and a markedly lower deaminating activity for deoxyadenosine relative to adenosine than does the 35,000-dalton ADA. A 100,000-dalton ADA isozyme has only recently been detected in mammalian tissues, where, in contrast to the chicken, it is only a trace component of total ADA activity. The human 100,000-dalton ADA isozyme, compared to the human 35,000-dalton ADA isozyme, has been reported to have a higher Km, a lower pH optimum, and a greater resistance to inhibition by erythro-9-(2-hydroxy-2-nonyl) adenine (EHNA). The similarity in KmS of the 100,000-dalton ADA isozyme in man and aves led us to hypothesize that these isozymes might be descended from a common ancestor and therefore also be similar as to other kinetic parameters. We now report that the chicken 100,000-dalton ADA, like the human 100,000-dalton isozyme, has a lower pH optimum and a greater resistance to inhibition by EHNA than does the avian or human 35,000-dalton isozyme. In addition, the avian 100,000-dalton isozyme is relatively resistant to inhibition by deoxycoformycin and has a cathodal rather than an anodal electrophoretic mobility at pH 6.5. Conversely, we report that the human 100,000-dalton ADA isozyme, similar to the avian 100,000-dalton ADA, has markedly lower relative deaminating activity for deoxyadenosine than does the 35,000-dalton ADA human isozyme. Thus, despite the marked difference in the relative amount of the 100,000- and 35,000-dalton ADA isozymes in man as compared to aves, the 100,000-dalton ADA isozymes from both species exhibit several similar kinetic properties, all of which are different from those of the 35,000-dalton ADA isozymes. We also report using a new sensitive assay, relative rates of degradation by the two chicken isozymes of several naturally occurring modified adenine nucleosides which are inhibitory to in vitro human lymphocyte proliferation.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7238474     DOI: 10.1159/000459153

Source DB:  PubMed          Journal:  Enzyme        ISSN: 0013-9432


  8 in total

1.  Human ADA2 belongs to a new family of growth factors with adenosine deaminase activity.

Authors:  Andrey V Zavialov; Ake Engström
Journal:  Biochem J       Date:  2005-10-01       Impact factor: 3.857

Review 2.  Adenosine deaminase, not immune to a mechanistic rethink in central nervous system disorders?

Authors:  Benjamin Hall; Jonathan G George; Scott P Allen
Journal:  Histol Histopathol       Date:  2021-12-09       Impact factor: 2.303

3.  Somatic mosaicism for a newly identified splice-site mutation in a patient with adenosine deaminase-deficient immunodeficiency and spontaneous clinical recovery.

Authors:  R Hirschhorn; D R Yang; A Israni; M L Huie; D R Ownby
Journal:  Am J Hum Genet       Date:  1994-07       Impact factor: 11.025

4.  Adenosine deaminase isoenzyme levels in patients with human T-cell lymphotropic virus type 1 and human immunodeficiency virus type 1 infections.

Authors:  I Tsuboi; K Sagawa; S Shichijo; M M Yokoyama; D W Ou; M D Wiederhold
Journal:  Clin Diagn Lab Immunol       Date:  1995-09

5.  Expression of Drosophila adenosine deaminase in immune cells during inflammatory response.

Authors:  Milena Novakova; Tomas Dolezal
Journal:  PLoS One       Date:  2011-03-11       Impact factor: 3.240

6.  Inhibition of adenosine deaminase (ADA)-mediated metabolism of cordycepin by natural substances.

Authors:  Gen Li; Izumi Nakagome; Shuichi Hirono; Tomoo Itoh; Ryoichi Fujiwara
Journal:  Pharmacol Res Perspect       Date:  2015-02-10

7.  Development of Adenosine Deaminase-Specific IgY Antibodies: Diagnostic and Inhibitory Application.

Authors:  Agnieszka Łupicka-Słowik; Mateusz Psurski; Renata Grzywa; Kamila Bobrek; Patrycja Smok; Maciej Walczak; Andrzej Gaweł; Tadeusz Stefaniak; Józef Oleksyszyn; Marcin Sieńczyk
Journal:  Appl Biochem Biotechnol       Date:  2017-10-17       Impact factor: 2.926

8.  Adenosine Deaminase-2-Induced Hyperpermeability in Human Retinal Vascular Endothelial Cells Is Suppressed by MicroRNA-146b-3p.

Authors:  Yara A Samra; Heba M Saleh; Khaled A Hussein; Nehal M Elsherbiny; Ahmed S Ibrahim; Khaled Elmasry; Sadanand Fulzele; Mamdouh M El-Shishtawy; Laila A Eissa; Mohamed Al-Shabrawey; Gregory I Liou
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-02-01       Impact factor: 4.799

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.